RTDRX | VFFSX | RTDRX / VFFSX | |
Total Expense Ratio | 0.46 | 0.01 | 4,600% |
Annual Report Gross Expense Ratio | 0.48 | 0.01 | 4,800% |
Fund Existence | 10 years | 9 years | - |
Gain YTD | 12.343 | 12.255 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 376M | 1.37T | 0% |
Annual Yield % from dividends | 1.18 | 1.18 | 101% |
Returns for 1 year | -8.24 | 17.74 | -46% |
Returns for 3 years | 20.34 | 67.56 | 30% |
Returns for 5 years | 35.09 | 97.25 | 36% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSLLX | 24.03 | -0.01 | -0.04% |
Goldman Sachs Enhanced U.S. Equity Inv | |||
NSOPX | 18.08 | -0.04 | -0.22% |
North Star Opportunity A | |||
VTMNX | 19.25 | -0.07 | -0.36% |
Vanguard Developed Markets Index Instl | |||
JFNIX | 70.04 | -0.74 | -1.05% |
Janus Henderson Global Life Sciences I | |||
BMDSX | 20.56 | -0.31 | -1.49% |
Baird Mid Cap Growth Investor |